FDA Grants Traditional Approval To Selpercatinib For Locally Advanced Or Metastatic Solid Tumors
LLY•FDA approval
July 14 (Reuters) - FDA:
- FDA grants traditional approval to selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors
